Understanding integrative approach of translational bioinformatics on cardiovascular disease: Myocardial Ischemia

Understanding integrative approach of translational bioinformatics on cardiovascular disease: Myocardial Ischemia Yeswanth Ranganathan Saayaa Nazar Ravi Shankar Krishnan Yuvaraj Dinakarkumar Vijayalakshmi Varadarajan Lenita Sebastian Brindha Rethinam http://orcid.org/0000-0002-6029-1562 Abstract Background

Myocardial ischemia is a significant problem in cardiovascular health caused by the obstruction or constriction of coronary arteries, resulting in diminished blood supply to the heart muscle. Translational bioinformatics bridges the gap between biological discoveries and clinical applications, enabling early disease identification, therapy response confirmation, and prognosis prediction. It facilitates the integration and analysis of vast amounts of clinical data, hence advancing clinical research and enhancing therapeutic approaches.
Main body

This review explores the role of translational bioinformatics in understanding and treating cardiovascular disease, specifically Myocardial Ischemia. It covers the discovery of novel biomarkers (miRNA, lncRNA, and tsRNA), analysis of genes and proteins, and integrated bioinformatics to identify differentially expressed genes. The study highlights the impact of personalized medicine, drug discovery, and repurposing through bioinformatics. Additionally, it examines the application of systems biology and network analysis to understand biological networks, and the use of clinical decision support systems to enhance patient care. This integrative approach demonstrates the potential of bioinformatics to improve cardiovascular health outcomes.
Conclusions

Combining clinical and omics data using translational bioinformatics is critical for refining treatment regimens and speeding up medication repurposing. This comprehensive study emphasizes the necessity of combining interdisciplinary data to enhance patient outcomes in myocardial ischemia, minimize the global burden of cardiovascular-related deaths, and improve cardiovascular disease management.
Graphical abstract 12 19 2024 153 622 1 10.1007/springer_crossmark_policy link.springer.com false 20 March 2024 5 December 2024 19 December 2024 3 February 2025 Correction A Correction to this paper has been published: https://doi.org/10.1186/s43042-025-00645-3 Not applicable. Not applicable. The authors declare that they have no competing interests. https://creativecommons.org/licenses/by/4.0 https://creativecommons.org/licenses/by/4.0 10.1186/s43042-024-00622-2 20250204082406978 https://jmhg.springeropen.com/articles/10.1186/s43042-024-00622-2 https://link.springer.com/content/pdf/10.1186/s43042-024-00622-2.pdf https://link.springer.com/content/pdf/10.1186/s43042-024-00622-2.pdf https://link.springer.com/article/10.1186/s43042-024-00622-2/fulltext.html Cardiovasc Ther JD Barua 2022 9034996 2022 10.1155/2022/9034996 Barua JD, Sen Omit SB, Rana HK, Podder NK, Chowdhury UN, Rahman MH (2022) Bioinformatics and system biological approaches for the identification of genetic risk factors in the progression of cardiovascular disease. Cardiovasc Ther 2022:9034996. https://doi.org/10.1155/2022/9034996 Genom Proteom Bioinform JD Tenenbaum 14 1 31 2016 10.1016/J.GPB.2016.01.003 Tenenbaum JD (2016) Translational bioinformatics: past, present, and future. Genom Proteom Bioinform 14(1):31–41. https://doi.org/10.1016/J.GPB.2016.01.003 Brief Bioinform K Shameer 18 1 105 2017 10.1093/BIB/BBV118 Shameer K, Badgeley MA, Miotto R, Glicksberg BS, Morgan JW, Dudley JT (2017) Translational bioinformatics in the era of real-time biomedical, health care and wellness data streams. Brief Bioinform 18(1):105–124. https://doi.org/10.1093/BIB/BBV118 Drug Discov Today NS Buchan 16 9–10 426 2011 10.1016/J.DRUDIS.2011.03.002 Buchan NS et al (2011) The role of translational bioinformatics in drug discovery. Drug Discov Today 16(9–10):426–434. https://doi.org/10.1016/J.DRUDIS.2011.03.002 Sethi P, Theodos K (2009) Translational bioinformatics and healthcare informatics: computational and ethical challenges. Perspect Health Inf Manag/AHIMA, Am Health Inf Manag Assoc 6(Fall), Accessed: Jul. 23, 2024. [Online]. Available: /pmc/articles/PMC2804463/ Brief Bioinform MA Nashiry 22 6 1 2021 10.1093/BIB/BBAB126 Nashiry MA, Sumi SS, Sharif Shohan MU, Alyami SA, Azad AKM, Moni MA (2021) Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders. Brief Bioinform 22(6):1–16. https://doi.org/10.1093/BIB/BBAB126 Brief Bioinform RK Azad 20 6 1957 2019 10.1093/BIB/BBX170 Azad RK, Shulaev V (2019) Metabolomics technology and bioinformatics for precision medicine. Brief Bioinform 20(6):1957–1971. https://doi.org/10.1093/BIB/BBX170 Front Pharmacol M Wang 11 492421 2020 10.3389/FPHAR.2020.00957/BIBTEX Wang M et al (2020) Identification of hub genes in protective effect of astragaloside IV on aconitine-induced cardiac damage in zebrafish based on bioinformatics analysis. Front Pharmacol 11:492421. https://doi.org/10.3389/FPHAR.2020.00957/BIBTEX Front Cardiovasc Med HT Pan 9 1021112 2022 10.3389/FCVM.2022.1021112 Pan HT et al (2022) Proteomics and bioinformatics analysis of cardiovascular related proteins in offspring exposed to gestational diabetes mellitus. Front Cardiovasc Med 9:1021112. https://doi.org/10.3389/FCVM.2022.1021112 Circ Res P Joseph 121 6 677 2017 10.1161/CIRCRESAHA.117.308903/ASSET/B63DB805-8E70-48A6-9A7E-FEBBF6190BF8/ASSETS/GRAPHIC/677FIG07.JPEG Joseph P et al (2017) Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res 121(6):677–694. https://doi.org/10.1161/CIRCRESAHA.117.308903/ASSET/B63DB805-8E70-48A6-9A7E-FEBBF6190BF8/ASSETS/GRAPHIC/677FIG07.JPEG Brief Bioinform BB Khomtchouk 21 6 2031 2020 10.1093/BIB/BBZ119 Khomtchouk BB, Tran DT, Vand KA, Might M, Gozani O, Assimes TL (2020) Cardioinformatics: the nexus of bioinformatics and precision cardiology. Brief Bioinform 21(6):2031. https://doi.org/10.1093/BIB/BBZ119 Brief Bioinform K Shameer 19 4 656 2018 10.1093/BIB/BBW136 Shameer K et al (2018) Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning. Brief Bioinform 19(4):656–678. https://doi.org/10.1093/BIB/BBW136 Int J Mol Sci T Behl 22 12 6184 2021 10.3390/IJMS22126184 Behl T et al (2021) Bioinformatics accelerates the major tetrad: a real boost for the pharmaceutical industry. Int J Mol Sci 22(12):6184. https://doi.org/10.3390/IJMS22126184 Biol Chem BG Hill 401 1 3 2019 10.1515/HSZ-2019-0268 Hill BG, Shiva S, Ballinger S, Zhang J, Darley-Usmar VM (2019) Bioenergetics and translational metabolism: implications for genetics, physiology and precision medicine. Biol Chem 401(1):3. https://doi.org/10.1515/HSZ-2019-0268 Evid Based Complement Alternat Med J Wang 2022 2056630 2022 10.1155/2022/2056630 Wang J, Li X, Peng G, Fan G, Zhang M, Chen J (2022) Integrated bioinformatics analysis and verification of gene targets for myocardial ischemia-reperfusion injury. Evid Based Complement Alternat Med 2022:2056630. https://doi.org/10.1155/2022/2056630 Cells L Schirone 11 7 1165 2022 10.3390/CELLS11071165 Schirone L et al (2022) An overview of the molecular mechanisms associated with myocardial ischemic injury: state of the art and translational perspectives. Cells 11(7):1165. https://doi.org/10.3390/CELLS11071165 Clin Pharmacol Ther RB Altman 91 6 994 2012 10.1038/CLPT.2012.49 Altman RB (2012) Translational bioinformatics: linking the molecular world to the clinical world. Clin Pharmacol Ther 91(6):994. https://doi.org/10.1038/CLPT.2012.49 Front Cardiovasc Med G Sun 8 630471 2021 10.3389/FCVM.2021.630471 Sun G et al (2021) A bioinformatics perspective on the links between tetraspanin-enriched microdomains and cardiovascular pathophysiology. Front Cardiovasc Med 8:630471. https://doi.org/10.3389/FCVM.2021.630471 Int J Mol Sci Z Wu 24 8 7339 2023 10.3390/IJMS24087339 Wu Z et al (2023) Identification of signature genes of dilated cardiomyopathy using integrated bioinformatics analysis. Int J Mol Sci 24(8):7339. https://doi.org/10.3390/IJMS24087339 Eur Rev Med Pharmacol Sci GM Li 22 11 3553 2018 10.26355/EURREV_201806_15182 Li GM, Zhang CL, Rui RP, Sun B, Guo W (2018) Bioinformatics analysis of common differential genes of coronary artery disease and ischemic cardiomyopathy. Eur Rev Med Pharmacol Sci 22(11):3553–3569. https://doi.org/10.26355/EURREV_201806_15182 Circ Res M Leblanc 118 1 83 2016 10.1161/CIRCRESAHA.115.306629 Leblanc M et al (2016) Identifying novel gene variants in coronary artery disease and shared genes with several cardiovascular risk factors. Circ Res 118(1):83–94. https://doi.org/10.1161/CIRCRESAHA.115.306629 Nat Genet H Schunkert 43 4 333 2011 10.1038/NG.784 Schunkert H et al (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43(4):333–340. https://doi.org/10.1038/NG.784 J Educ Health Promot S Ramesh 12 1 41 2023 10.4103/JEHP.JEHP_1113_22 Ramesh S, Kosalram K (2023) The burden of non-communicable diseases: a scoping review focus on the context of India. J Educ Health Promot 12(1):41. https://doi.org/10.4103/JEHP.JEHP_1113_22 J Am Coll Cardiol GA Mensah 74 20 2529 2019 10.1016/J.JACC.2019.10.009 Mensah GA, Roth GA, Fuster V (2019) The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol 74(20):2529–2532. https://doi.org/10.1016/J.JACC.2019.10.009 Clin Sci (Lond) Y Cheng 119 2 87 2010 10.1042/CS20090645 Cheng Y et al (2010) A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond) 119(2):87. https://doi.org/10.1042/CS20090645 Genom Proteom Bioinform Y Kong 3 2 62 2005 10.1016/S1672-0229(05)03011-1 Kong Y, Han JH (2005) MicroRNA: biological and computational perspective. Genom Proteom Bioinform 3(2):62–72. https://doi.org/10.1016/S1672-0229(05)03011-1 MicroRNAs: biogenesis, function and applications-PubMed. Accessed: Jul. 23, 2024. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/19330724/ J Immunol Res Y Han 2022 7260801 2022 10.1155/2022/7260801 Han Y et al (2022) Integrated bioinformatics and validation of lncRNA-mediated ceRNA network in myocardial ischemia/reperfusion injury. J Immunol Res 2022:7260801. https://doi.org/10.1155/2022/7260801 Cell Death Differ G Zhang 29 4 750 2022 10.1038/S41418-021-00889-7 Zhang G, Wang X, Rothermel BA, Lavandero S, Wang ZV (2022) The integrated stress response in ischemic diseases. Cell Death Differ 29(4):750–757. https://doi.org/10.1038/S41418-021-00889-7 Antioxidants (Basel) J Zhang 9 9 1 2020 10.3390/ANTIOX9090858 Zhang J, Ren D, Fedorova J, He Z, Li J (2020) SIRT1/SIRT3 modulates redox homeostasis during ischemia/reperfusion in the aging heart. Antioxidants (Basel) 9(9):1–16. https://doi.org/10.3390/ANTIOX9090858 Phytomedicine Z Yu Yang 102 154168 2022 10.1016/J.PHYMED.2022.154168 Yu Yang Z et al (2022) Systematic analysis of tRNA-derived small RNAs reveals therapeutic targets of Xuefu Zhuyu decoction in the cortexes of experimental traumatic brain injury. Phytomedicine 102:154168. https://doi.org/10.1016/J.PHYMED.2022.154168 BMC Biol P Kumar 12 1 1 2014 10.1186/S12915-014-0078-0 Kumar P, Anaya J, Mudunuri SB, Dutta A (2014) Meta-analysis of tRNA derived RNA fragments reveals that they are evolutionarily conserved and associate with AGO proteins to recognize specific RNA targets. BMC Biol 12(1):1–14. https://doi.org/10.1186/S12915-014-0078-0 Circulation I Ahmet 112 20 3115 2005 10.1161/CIRCULATIONAHA.105.563817 Ahmet I, Wan R, Mattson MP, Lakatta EG, Talan M (2005) Cardioprotection by intermittent fasting in rats. Circulation 112(20):3115–3121. https://doi.org/10.1161/CIRCULATIONAHA.105.563817 Cardiovasc Drugs Ther C Moon 19 4 243 2005 10.1007/S10557-005-3189-6 Moon C, Krawczyk M, Paik D, Lakatta EG, Talan MI (2005) Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window. Cardiovasc Drugs Ther 19(4):243–250. https://doi.org/10.1007/S10557-005-3189-6 Gene H Li 596 98 2017 10.1016/J.GENE.2016.09.037 Li H, Zhao X, Wang J, Zong M, Yang H (2017) Bioinformatics analysis of gene expression profile data to screen key genes involved in pulmonary sarcoidosis. Gene 596:98–104. https://doi.org/10.1016/J.GENE.2016.09.037 Int J Mol Sci C Chen 22 23 13116 2021 10.3390/IJMS222313116/S1 Chen C, Tian J, He Z, Xiong W, He Y, Liu S (2021) Identified three interferon induced proteins as novel biomarkers of human ischemic cardiomyopathy. Int J Mol Sci 22(23):13116. https://doi.org/10.3390/IJMS222313116/S1 Stat Appl Genet Mol Biol B Zhang 2005 10.2202/1544-6115.1128 Zhang B, Horvath S (2005) A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. https://doi.org/10.2202/1544-6115.1128 Nat Med KR King 23 12 1481 2017 10.1038/nm.4428 King KR et al (2017) IRF3 and type I interferons fuel a fatal response to myocardial infarction. Nat Med 23(12):1481–1487. https://doi.org/10.1038/nm.4428 PLoS Pathog T Kimura 15 4 e1007674 2019 10.1371/JOURNAL.PPAT.1007674 Kimura T, Flynn CT, Alirezaei M, Sen GC, Whitton JL (2019) Biphasic and cardiomyocyte-specific IFIT activity protects cardiomyocytes from enteroviral infection. PLoS Pathog 15(4):e1007674. https://doi.org/10.1371/JOURNAL.PPAT.1007674 Cardiovasc Res MV Basalay 112 3 669 2016 10.1093/CVR/CVW216 Basalay MV et al (2016) Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning. Cardiovasc Res 112(3):669. https://doi.org/10.1093/CVR/CVW216 Am J Physiol Endocrinol Metab M DeNicola 307 8 E630 2014 10.1152/AJPENDO.00109.2014 DeNicola M et al (2014) Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium. Am J Physiol Endocrinol Metab 307(8):E630–E643. https://doi.org/10.1152/AJPENDO.00109.2014 World J Pharmacol D Cervia 1 2 30 2012 10.5497/WJP.V1.I2.30 Cervia D, Casini G (2012) Recent advances in cellular and molecular aspects of mammalian retinal ischemia. World J Pharmacol 1(2):30–43. https://doi.org/10.5497/WJP.V1.I2.30 Clin Sci (Lond) MP Ocaranza 132 16 1837 2018 10.1042/CS20180312 Ocaranza MP et al (2018) Rho kinase activation in circulating leukocytes is related to hypertensive myocardial remodeling. Clin Sci (Lond) 132(16):1837–1853. https://doi.org/10.1042/CS20180312 Int J Environ Res Public Health J Schmidt-Riovalle 17 22 1 2020 10.3390/IJERPH17228439 Schmidt-Riovalle J et al (2020) Quality of life after coronary artery bypass surgery: a systematic review and meta-analysis. Int J Environ Res Public Health 17(22):1–12. https://doi.org/10.3390/IJERPH17228439 Front Microbiol L Wang 13 883734 2022 10.3389/FMICB.2022.883734/BIBTEX Wang L et al (2022) Metaomics in clinical laboratory: potential driving force for innovative disease diagnosis. Front Microbiol 13:883734. https://doi.org/10.3389/FMICB.2022.883734/BIBTEX 10.3389/fphar.2021.707394 Zhang X-X, Liang B, Shao C-L, Gu N (2021) Traditional chinese medicine intervenes ventricular remodeling following acute myocardial infarction: evidence from 40 random controlled trials with 3,659 subjects. Front Pharmacol 12:707394. https://doi.org/10.3389/fphar.2021.707394 Pharmacol Res K Wang 170 105743 2021 10.1016/J.PHRS.2021.105743 Wang K, Li Y, Qiang T, Chen J, Wang X (2021) Role of epigenetic regulation in myocardial ischemia/reperfusion injury. Pharmacol Res 170:105743. https://doi.org/10.1016/J.PHRS.2021.105743 J Am Coll Cardiol B Ibáñez 65 14 1454 2015 10.1016/J.JACC.2015.02.032 Ibáñez B, Heusch G, Ovize M, Van De Werf F (2015) Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol 65(14):1454–1471. https://doi.org/10.1016/J.JACC.2015.02.032 Biochem Biophys Res Commun G Zeng 502 1 15 2018 10.1016/J.BBRC.2018.05.113 Zeng G, Liu H, Wang H (2018) Amelioration of myocardial ischemia-reperfusion injury by SIRT4 involves mitochondrial protection and reduced apoptosis. Biochem Biophys Res Commun 502(1):15–21. https://doi.org/10.1016/J.BBRC.2018.05.113 Circ Cardiovasc Qual Outcomes P Wu 10 2 e003497 2017 10.1161/CIRCOUTCOMES.116.003497/SUPPL_FILE/CIRCCVQO_CIRCCQO-2016-003497-T_SUPP1.PDF Wu P et al (2017) Preeclampsia and future cardiovascular health. Circ Cardiovasc Qual Outcomes 10(2):e003497. https://doi.org/10.1161/CIRCOUTCOMES.116.003497/SUPPL_FILE/CIRCCVQO_CIRCCQO-2016-003497-T_SUPP1.PDF J Am Coll Cardiol R Ahmed 63 18 1815 2014 10.1016/J.JACC.2014.02.529 Ahmed R, Dunford J, Mehran R, Robson S, Kunadian V (2014) Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol 63(18):1815–1822. https://doi.org/10.1016/J.JACC.2014.02.529 Precision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular disease-PubMed. Accessed: Jul. 23, 2024. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/27347303/ Circ Heart Fail GJ Haas 15 5 e008877 2022 10.1161/CIRCHEARTFAILURE.121.008877 Haas GJ, Zareba KM, Ni H, Bello-Pardo E, Huggins GS, Hershberger RE (2022) Validating an idiopathic dilated cardiomyopathy diagnosis using cardiovascular magnetic resonance: the DCM precision medicine study. Circ Heart Fail 15(5):e008877. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008877 Circulation JA McCrohon 108 1 54 2003 10.1161/01.CIR.0000078641.19365.4C McCrohon JA et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108(1):54–59. https://doi.org/10.1161/01.CIR.0000078641.19365.4C Circ Res RE Hershberger 128 10 1514 2021 10.1161/CIRCRESAHA.121.318157 Hershberger RE, Cowan J, Jordan E, Kinnamon DD (2021) The complex and diverse genetic architecture of dilated cardiomyopathy. Circ Res 128(10):1514–1532. https://doi.org/10.1161/CIRCRESAHA.121.318157 J Toxicol EM Alissa 2011 1 870125 2011 10.1155/2011/870125 Alissa EM, Ferns GA (2011) Heavy metal poisoning and cardiovascular disease. J Toxicol 2011(1):870125. https://doi.org/10.1155/2011/870125 Circulation CA MacRae 133 25 2634 2016 10.1161/CIRCULATIONAHA.116.022547 MacRae CA, Vasan RS (2016) The future of genetics and genomics. Circulation 133(25):2634–2639. https://doi.org/10.1161/CIRCULATIONAHA.116.022547 Circ Res MMG Van Den Hoogenhof 118 3 454 2016 10.1161/CIRCRESAHA.115.307872/ASSET/94EC3776-CB83-4F40-932B-3DAF533FD71E/ASSETS/GRAPHIC/454FIG03.JPEG Van Den Hoogenhof MMG, Pinto YM, Creemers EE (2016) RNA splicing regulation and dysregulation in the heart. Circ Res 118(3):454–468. https://doi.org/10.1161/CIRCRESAHA.115.307872/ASSET/94EC3776-CB83-4F40-932B-3DAF533FD71E/ASSETS/GRAPHIC/454FIG03.JPEG J Am Coll Cardiol MPY Lam 68 25 2819 2016 10.1016/J.JACC.2016.10.031 Lam MPY, Ping P, Murphy E (2016) Proteomics research in cardiovascular medicine and biomarker discovery. J Am Coll Cardiol 68(25):2819. https://doi.org/10.1016/J.JACC.2016.10.031 J Am Coll Cardiol GD Lewis 52 2 117 2008 10.1016/J.JACC.2008.03.043 Lewis GD, Asnani A, Gerszten RE (2008) Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol 52(2):117. https://doi.org/10.1016/J.JACC.2008.03.043 Nat Rev Genet AL Barabási 12 1 56 2010 10.1038/nrg2918 Barabási AL, Gulbahce N, Loscalzo J (2010) Network medicine: a network-based approach to human disease. Nat Rev Genet 12(1):56–68. https://doi.org/10.1038/nrg2918 Nat Rev Cardiol M Abdelsayed 19 11 751 2022 10.1038/s41569-022-00717-6 Abdelsayed M, Kort EJ, Jovinge S, Mercola M (2022) Repurposing drugs to treat cardiovascular disease in the era of precision medicine. Nat Rev Cardiol 19(11):751–764. https://doi.org/10.1038/s41569-022-00717-6 N Engl J Med WG Feero 365 22 2098 2011 10.1056/NEJMRA1105239 Feero WG, Guttmacher AE, O’donnell CJ, Nabel EG (2011) Genomics of cardiovascular disease. N Engl J Med 365(22):2098–2109. https://doi.org/10.1056/NEJMRA1105239 Circulation MS Sabatine 112 25 3868 2005 10.1161/CIRCULATIONAHA.105.569137/SUPPL_FILE/CI501532.OLSUPPTAB.DOC Sabatine MS et al (2005) Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112(25):3868–3875. https://doi.org/10.1161/CIRCULATIONAHA.105.569137/SUPPL_FILE/CI501532.OLSUPPTAB.DOC Clin Chem DA Morrow 49 4 537 2003 10.1373/49.4.537 Morrow DA, De Lemos JA, Sabatine MS, Antman EM (2003) The search for a biomarker of cardiac ischemia. Clin Chem 49(4):537–539. https://doi.org/10.1373/49.4.537 Evid Based Complement Alternat Med J Lu 2018 7956503 2018 10.1155/2018/7956503 Lu J et al (2018) Understanding the multitarget pharmacological mechanism of the traditional Mongolian common herb pair GuangZao-RouDouKou acting on coronary heart disease based on a bioinformatics approach. Evid Based Complement Alternat Med 2018:7956503. https://doi.org/10.1155/2018/7956503 Sci Rep YH Sun 11 1 664 2021 10.1038/s41598-020-80861-6 Sun YH et al (2021) Validation of efficacy and mechanism of Sanwei-Tanxiang powder in improving myocardial ischemia reperfusion injuries. Sci Rep 11(1):664. https://doi.org/10.1038/s41598-020-80861-6 J Ethnopharmacol W Tao 145 1 1 2013 10.1016/J.JEP.2012.09.051 Tao W et al (2013) Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol 145(1):1–10. https://doi.org/10.1016/J.JEP.2012.09.051 PLoS Comput Biol NT Nguyen 10 3 e1003472 2014 10.1371/JOURNAL.PCBI.1003472 Nguyen NT et al (2014) Integrative computational and experimental approaches to establish a post-myocardial infarction knowledge map. PLoS Comput Biol 10(3):e1003472. https://doi.org/10.1371/JOURNAL.PCBI.1003472 “The role of the renin-angiotensin system in the pathophysiology of cardiac remodeling - PubMed.” Accessed: Jul. 23, 2024. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/8913534/ Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts-PubMed. Accessed: Jul. 23, 2024. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/8575002/ J Mol Cell Cardiol R Zamilpa 53 5 599 2012 10.1016/J.YJMCC.2012.07.017 Zamilpa R et al (2012) Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction. J Mol Cell Cardiol 53(5):599–608. https://doi.org/10.1016/J.YJMCC.2012.07.017 Emerg Med Clin North Am JH Pope 21 1 27 2003 10.1016/S0733-8627(02)00079-2 Pope JH, Selker HP (2003) Diagnosis of acute cardiac ischemia. Emerg Med Clin North Am 21(1):27–59. https://doi.org/10.1016/S0733-8627(02)00079-2 Circulation FS Villanueva 115 3 345 2007 10.1161/CIRCULATIONAHA.106.633917/ASSET/9E554DB5-A795-4D71-8A4B-015E49F185DF/ASSETS/GRAPHIC/12FF6.JPEG Villanueva FS et al (2007) Myocardial ischemic memory imaging with molecular echocardiography. Circulation 115(3):345–352. https://doi.org/10.1161/CIRCULATIONAHA.106.633917/ASSET/9E554DB5-A795-4D71-8A4B-015E49F185DF/ASSETS/GRAPHIC/12FF6.JPEG Circulation JP Christiansen 105 15 1764 2002 10.1161/01.CIR.0000015466.89771.E2 Christiansen JP, Leong-Poi H, Klibanov AL, Kaul S, Lindner JR (2002) Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation 105(15):1764–1767. https://doi.org/10.1161/01.CIR.0000015466.89771.E2 Am J Emerg Med CW Burt 17 6 552 1999 10.1016/S0735-6757(99)90195-X Burt CW (1999) Summary statistics for acute cardiac ischemia and chest pain visits to United States EDs, 1995–1996. Am J Emerg Med 17(6):552–559. https://doi.org/10.1016/S0735-6757(99)90195-X Am J Cardiol TH Lee 60 4 219 1987 10.1016/0002-9149(87)90217-7 Lee TH et al (1987) Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 60(4):219–224. https://doi.org/10.1016/0002-9149(87)90217-7